Delivery Order SPE2DB20D1100-SPE2DB25FD9S1
Award Date 8/11/25
Potential Completion Date 8/12/25
Potential Value $4.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $1,501.90 delivery order to AmerisourceBergen Drug Corp for Gadavist 10 mmol/10 ml vials, with an ultimate completion date of July 21, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $2,961.64 to AmerisourceBergen Drug Corp for Gadavist 10 mmol/10 ml vials. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement and is scheduled for completion by July 21, 2025. The product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- This is a $2,366.62 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for the pharmaceutical product Gadavist, a 10 milliliter vial containing 10 millimoles per milliliter. The delivery order has a completion date of June 11, 2025 and is not set aside for any small business categories. AmerisourceBergen Drug Corp holds a $999,999,999 Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,102.66 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Gadavist 10 mmol/10 ml vials. This non-set-aside, firm fixed price contract is scheduled for ultimate completion by July 31, 2025, with performance occurring at the vendor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills this order as a child...
- This is a $1,040.96 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is to supply the drug Gadavist, a contrast agent used in medical imaging procedures. The delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Gadavist, a 10 milliliter vial of a 10 millimolar per milliliter injectable contrast agent used in medical imaging. The delivery order has a firm fixed price of $2,736.24 and a period of performance ending on April 17, 2025. This award is not associated with a set-aside program and is...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,009.10, is for the delivery of Gadavist, a medication used in magnetic resonance imaging (MRI) procedures. The contract is a firm fixed-price delivery order and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at approximately $719 to Amerisourcebergen Drug Corporation for Gadavist, a contrast agent used in magnetic resonance imaging. To be performed over a one day period in Conshohocken, Pennsylvania, the firm fixed price contract calls for the delivery of 10 millimoles of Gadavist in 10 milliliter vials. As a major provider of medical supplies and pharmaceuticals to the Department of Defense, Amerisourcebergen will fulfill this order...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The contract, valued at $1,962.44, is for the supply of Gadavist, a 10 mmol/10 ml vial medication, with a period of performance through March 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $8,258.75 contract is for the supply of Gadavist, a 10 mL vial of contrast agent used in medical imaging procedures. The delivery order is part of a larger indefinite delivery contract (IDC) with a potential value up to $999,999,999.00, which serves as the primary contract...